Clinical trials
Kidney Diseases trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
80 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 2 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 5 |
| 2025 | 12 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Recruiting | 18 |
| Unknown status | 11 |
| Active, not recruiting | 8 |
| Terminated | 6 |
| Not yet recruiting | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 8 |
| AstraZeneca | 4 |
| Novartis Pharmaceuticals | 4 |
| University Hospital, Strasbourg, France | 4 |
| University Hospital, Toulouse | 3 |
| University Hospital, Tours | 3 |
| Bayer | 2 |
| Eli Lilly and Company | 2 |
| Genfit | 2 |
| Genzyme, a Sanofi Company | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Diseases | 80 |
| Renal Insufficiency, Chronic | 15 |
| Urologic Diseases | 7 |
| Diabetic Nephropathies | 6 |
| Heart Diseases | 6 |
| Kidney Failure, Chronic | 6 |
| Glomerulonephritis, IGA | 5 |
| Renal Insufficiency | 5 |
| Diabetes Mellitus, Type 2 | 4 |
| Glomerulonephritis | 4 |
Trials
Showing 76 to 80 of 80. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.